Locations
Menlo Park, CA, USA · Redwood City, CA, USA · Redwood Shores, Redwood City, CA, USA
industry
Biotechnology · DeepTech · Health
Size
11-50 employees
Stage
Series B
founded in
2021
Nuvig Therapeutics is a pioneering organization focused on developing next-generation immune modulators for chronic inflammatory and autoimmune diseases. Their innovative approach targets the underlying mechanisms of autoimmune dysregulation, aiming to improve patient outcomes without compromising immune function. With a dedicated team of experienced scientists and drug developers, Nuvig is advancing a pipeline of novel therapies, including the next-generation immune modulator NVG-2089, which is currently in clinical development. The company is positioned to transform the treatment landscape for autoimmune diseases, addressing a significant unmet need in the market.
Something looks off?On-site & Remote